MyD88 Is Pivotal for the Early Inflammatory Response and Subsequent Bacterial Clearance and Survival in a Mouse Model of Chlamydia pneumoniae Pneumonia

Yoshikazu Naiki, Kathrin S. Michelsen, Nicolas W.J. Schröder, Randa Alsabeh, Anatoly Slepenkin, Wenxuan Zhang, Shuang Chen, Bo Wei, Yonca Bulut, Michelle Wong,

Journal of Biological Chemistry · 2005 · 97 citations · 22 references

DOIFull text

Open access

Concepts

Abstract

Chlamydia pneumoniae is the causative agent of respiratory tract infections and a number of chronic diseases. Here we investigated the involvement of the common TLR adaptor molecule MyD88 in host responses to C. pneumoniae-induced pneumonia in mice. MyD88-deficient mice were severely impaired in their ability to mount an acute early inflammatory response toward C. pneumoniae. Although the bacterial burden in the lungs was comparable 5 days after infection, MyD88-deficient mice exhibited only minor signs of pneumonia and reduced expression of inflammatory mediators. MyD88-deficient mice were unable to up-regulate proinflammatory cytokines and chemokines, demonstrated delayed recruitment of CD8+ and CD4+ T cells to the lungs, and were unable to clear the pathogen from their lungs at day 14. At day 14 the MyD88-deficent mice developed a severe, chronic lung inflammation with elevated IL-1β and IFN-γ leading to increased mortality, whereas wild-type mice as well as TLR2- or TLR4-deficient mice recovered from acute pneumonia and did not show delayed bacterial clearance. Thus, MyD88 is essential to recognize C. pneumoniae infection and initiate a prompt and effective immune host response against this organism leading to clearance of bacteria from infected lungs. Chlamydia pneumoniae is the causative agent of respiratory tract infections and a number of chronic diseases. Here we investigated the involvement of the common TLR adaptor molecule MyD88 in host responses to C. pneumoniae-induced pneumonia in mice. MyD88-deficient mice were severely impaired in their ability to mount an acute early inflammatory response toward C. pneumoniae. Although the bacterial burden in the lungs was comparable 5 days after infection, MyD88-deficient mice exhibited only minor signs of pneumonia and reduced expression of inflammatory mediators. MyD88-deficient mice were unable to up-regulate proinflammatory cytokines and chemokines, demonstrated delayed recruitment of CD8+ and CD4+ T cells to the lungs, and were unable to clear the pathogen from their lungs at day 14. At day 14 the MyD88-deficent mice developed a severe, chronic lung inflammation with elevated IL-1β and IFN-γ leading to increased mortality, whereas wild-type mice as well as TLR2- or TLR4-deficient mice recovered from acute pneumonia and did not show delayed bacterial clearance. Thus, MyD88 is essential to recognize C. pneumoniae infection and initiate a prompt and effective immune host response against this organism leading to clearance of bacteria from infected lungs. Members of the family Chlamydiaceae are obligate intracellular pathogens that cause a wide variety of human diseases that include ocular, pulmonary, and genital infections (1Belland R. Ojcius D.M. Byrne G.I. Nat. Rev. Microbiol. 2004; 2: 530-531Crossref PubMed Scopus (67) Google Scholar, 2Campbell L.A. Kuo C.C. Nat. Rev. Microbiol. 2004; 2: 23-32Crossref PubMed Scopus (252) Google Scholar). Within this family Chlamydia pneumoniae is in particular clinically important, not only because it has a worldwide distribution and is responsible for about 10% of community-acquired pneumonia and 5% of sinusitis and bronchitis, but also because it has been strongly implicated as a major contributor to vascular diseases such as atherosclerosis (2Campbell L.A. Kuo C.C. Nat. Rev. Microbiol. 2004; 2: 23-32Crossref PubMed Scopus (252) Google Scholar, 3Kuo C.C. Jackson L.A. Campbell L.A. Grayston J.T. Clin. Microbiol. Rev. 1995; 8: 451-461Crossref PubMed Google Scholar, 4Belland R.J. Ouellette S.P. Gieffers J. Byrne G.I. Cell Microbiol. 2004; 6: 117-127Crossref PubMed Scopus (136) Google Scholar) and chronic lung disease such as asthma (5Hansbro P.M. Beagley K.W. Horvat J.C. Gibson P.G. Pharmacol. Ther. 2004; 101: 193-210Crossref PubMed Scopus (88) Google Scholar). A compelling body of evidence indicates that the host critically relies upon Toll-like receptors (TLRs) 1The abbreviations used are: TLRs, Toll-like receptors; MyD88, myeloid differentiation factor 88; WT, wild-type; BAL, bronchoalveolar lavage; TIR, Toll/IL-1 receptor; IFU, inclusion forming unit; TRIF, Toll/IL-1 receptor domain-containing adaptor inducing interferon-β; TRAM TRIF-related adaptor molecule; IL, interleukin; MOI, multiplicity of infection; ELISA, enzyme-linked immunosorbent assay; mAb, monoclonal antibody; DMEM, Dulbecco's modified Eagle's medium; FCS, fetal calf serum; IFN, interferon; PMN, polymorphonuclear cell; FACS, fluorescent-activated cell sorter; LPS, lipopolysaccharide. 1The abbreviations used are: TLRs, Toll-like receptors; MyD88, myeloid differentiation factor 88; WT, wild-type; BAL, bronchoalveolar lavage; TIR, Toll/IL-1 receptor; IFU, inclusion forming unit; TRIF, Toll/IL-1 receptor domain-containing adaptor inducing interferon-β; TRAM TRIF-related adaptor molecule; IL, interleukin; MOI, multiplicity of infection; ELISA, enzyme-linked immunosorbent assay; mAb, monoclonal antibody; DMEM, Dulbecco's modified Eagle's medium; FCS, fetal calf serum; IFN, interferon; PMN, polymorphonuclear cell; FACS, fluorescent-activated cell sorter; LPS, lipopolysaccharide. to sense the presence of foreign pathogens and initiate both rapid and sustained defenses (6Akira S. Takeda K. Nat. Rev. Immunol. 2004; 4: 499-511Crossref PubMed Scopus (6623) Google Scholar, 7Beutler B. Nature. 2004; 430: 257-263Crossref PubMed Scopus (1247) Google Scholar). Association of pathogen-associated molecular patterns (PAMPs) with their cognate TLRs initiates signaling that requires assemblies of heteromeric complexes composed of dimerized TLRs, together with one or more adaptor molecules for effective downstream transmission and transcriptional responses that defend against the pathogen and activate a variety of other defensive mechanisms. Most (but not all) TLR signaling involves the adaptor molecule MyD88 (myeloid differentiation factor 88), but MyD88-independent responses are important though poorly understood. MyD88-/- mice are unable to mount a vigorous Th1 response, and instead Th2 polarization predominates. Whereas some studies indicate that long term adaptive responses may be preserved, other data support a model wherein adaptive responses are critically dependent upon intact TLR signaling, and hence MyD88 (8Doherty T.M. Arditi M. J. Clin. Investig. 2004; 114: 1699-1703Crossref PubMed Scopus (55) Google Scholar). Furthermore, in some cases it appears that late activation of inflammatory cytokines can occur in the absence of MyD88. Mice deficient in MyD88 are markedly susceptible to systemic challenge with Staphylococcus aureus or Listeria monocytogenes (9Takeuchi O. Hoshino K. Akira S. J. Immunol. 2000; 165: 5392-5396Crossref PubMed Scopus (902) Google Scholar, 10Seki E. Tsutsui H. Tsuji N.M. Hayashi N. Adachi K. Nakano H. Futatsugi-Yumikura S. Takeuchi O. Hoshino K. Akira S. Fujimoto J. Nakanishi K. J. Immunol. 2002; 169: 3863-3868Crossref PubMed Scopus (240) Google Scholar, 11Way S.S. Kollmann T.R. Hajjar A.M. Wilson C.B. J. Immunol. 2003; 171: 533-537Crossref PubMed Scopus (59) Google Scholar, 12Edelson B.T. Unanue E.R. J. Immunol. 2002; 169: 3869-3875Crossref PubMed Scopus (195) Google Scholar), but are partially protected from polymicrobial peritonitis, possibly because of attenuation of an injurious inflammatory response (13Prebeck S. Kirschning C. Durr S. da Costa C. Donath B. Brand K. Redecke V. Wagner H. Miethke T. J. Immunol. 2001; 167: 3316-3323Crossref PubMed Scopus (150) Google Scholar). MyD88-dependent responses were essential for effective lung defenses against pulmonary infection with Pseudomonas aeroginosa but not S. aureus (14Skerrett S.J. Liggitt H.D. Hajjar A.M. Wilson C.B. J. Immunol. 2004; 172: 3377-3381Crossref PubMed Scopus (156) Google Scholar). Therefore, the consequences of MyD88 deficiency appear to be both pathogen and tissue-specific, suggesting substantial complexity in innate defenses, whereby essential or redundant roles for specific components are dependent both on the nature and the site of infection (14Skerrett S.J. Liggitt H.D. Hajjar A.M. Wilson C.B. J. Immunol. 2004; 172: 3377-3381Crossref PubMed Scopus (156) Google Scholar). Several studies have investigated the potential interaction of C. pneumoniae with TLRs in vitro. Chlamydial heat shock protein 60 (HSP60) has been shown to signal via TLR4 (15Sasu S. LaVerda D. Qureshi N. Golenbock D.T. Beasley D. Circ. Res. 2001; 89: 244-250Crossref PubMed Scopus (246) Google Scholar, 16Bulut Y. Faure E. Thomas L. Equils O. Arditi M. J. Immunol. 2001; 167: 987-994Crossref PubMed Scopus (343) Google Scholar) and yet undefined non-LPS components of C. pneumoniae may stimulate cytokine release involving TLR2 (17Netea M.G. Kullberg B.J. Galama J.M. Stalenhoef A.F. Dinarello C.A. Van der Meer J.W. Eur. J. Immunol. 2002; 32: 1188-1195Crossref PubMed Scopus (96) Google Scholar). The utilization of TLRs by live C. pneumoniae is not completely understood. The induction of interferon-γ (IFN-γ), a crucial step in the elimination of C. pneumoniae and both MyD88-dependent and MyD88-independent signaling were found to be important and complementary for IFN-γ expression in macrophages after intracellular bacterial infection (18Rothfuchs A.G. Trumstedt C. Wigzell H. Rottenberg M.E. J. Immunol. 2004; 172: 6345-6353Crossref PubMed Scopus (58) Google Scholar). To clarify the role of MyD88 signaling in host defense against C. pneumoniae, we inoculated MyD88-/- and wild-type mice intranasally with C. pneumoniae and compared the immune response and survival among the genotypes. We found that MyD88 is critically important for mounting a rapid and effective lung defenses against C. pneumoniae. In the absence of MyD88, an acute host defense against infection by C. pneumoniae does not occur, and infected mice rapidly succumb to infection. Surprisingly, we also found that a robust MyD88-independent inflammatory response does develop considerably later. MyD88-deficient mice were unable to clear bacteria and showed a severe, chronic lung inflammation with elevated systemic IL-1β and local IL-1β and IFN-γ concentrations, and intact adaptive immune responses with similar levels of C. pneumoniae-specific Abs to wild-type mice. These responses nevertheless were associated with decreased survival in C. pneumoniae-infected MyD88-deficient mice. Mice—MyD88-/-, TLR2-/-, and TLR4-/- mice were kindly provided by Dr. S. Akira (Osaka University, Osaka, Japan). A homogenous population was established by backcrossing MyD88-, TLR2-, and TLR4-deficient mice to C57BL/6 mice for more than five generations. Mice were maintained under specific pathogen-free conditions, and were used at 8 weeks of age. All experiments were done according to Cedars-Sinai Medical Center Institutional Animal Care and Use Committee guidelines. C. pneumoniae Infection—C. pneumoniae CM-1 (ATCC, Manassas, VA) was propagated in HEp-2 cells as previously described (19Peterson E.M. Zhong G.M. Carlson E. de la Maza L.M. Infect. Immun. 1988; 56: 885-891Crossref PubMed Google Scholar). HEp-2 cells and the C. pneumoniae stocks were determined to be free of Mycoplasma contamination by PCR (20Ossewaarde J.M. de Vries A. Bestebroer T. Angulo A.F. Appl. Environ. Microbiol. 1996; 62: 328-331Crossref PubMed Google Scholar). Mice were anesthetized with isofluorane prior to intranasal application of 5 × 106 IFU of C. pneumoniae suspended in sucrose-phosphate-glutamate buffer (40 μl per nostril). This buffer alone does not induce inflammation after intranasal application (data not shown). BAL was collected with 0.5 ml of phosphate-buffered saline. The lavage fluid was centrifuged, and the supernatant was used for cytokine measurements. The pellet was resuspended in phosphate-buffered saline, and cell number was counted. were in ml of sucrose-phosphate-glutamate and at HEp-2 cells in were inoculated with ml of and lung were for at with for and with and recognize the and a protein of C. pneumoniae, were used to C. pneumoniae as previously described E.M. de la Maza L.M. L. H. Infect. Immun. PubMed Google Scholar). were in and and were by a to the genotypes. The of inflammation was an of or inflammation involving than 10% of lung or inflammation involving of lung or inflammation involving of lung and inflammation involving more than of lung of and were and were and with 10% and cells were with cell buffer and in was at days and 5 at day at day were × at day and the day for in with as the of mice were and the was A was and with a by of 5 × ml of and of the were by in and counted. We × cells per were to at a of × macrophages were to cells and for in as and of C. pneumoniae-specific cytokine in the BAL, lung or supernatant were and and IFN-γ was used to to C. pneumoniae-specific as described previously S. A.G. E.M. de la Maza L.M. 2003; PubMed Scopus Google Scholar). in the lungs after infection were by of lung were by the lung at for with A and and a cell were by buffer cells were with against cell for T cell were with mAb, mAb, or of were collected on a and are as was determined by or for survival studies was determined by A of than was MyD88 Mice from on 5 of a C. pneumoniae but to at 14 and the role of MyD88 in host defense against an acute C. pneumoniae infection MyD88-/- and mice were inoculated intranasally with C. pneumoniae and at day 5 of the infected lungs inflammation as by more with in whereas MyD88-/- mice did not show signs of inflammation day the lungs and pneumonia with of lung in whereas MyD88-/- mice showed or signs of lung inflammation The lung inflammation for was in infected mice compared with MyD88-/- mice on day 5 was a of the lung at days 14 and Whereas mice the lung MyD88-/- mice developed a severe, and chronic lung with a lung inflammation compared with mice on day that of the mice the lung whereas of MyD88-/- mice that severe, chronic lung inflammation Whereas the acute inflammation at day 5 in the lungs of mice showed polymorphonuclear cell the inflammation on day 14 in the lungs of MyD88-/- mice showed cells and some cell but MyD88 the to C. pneumoniae the role of MyD88 in inflammatory host responses against C. pneumoniae infection, we the body of MyD88-/- and mice and 5 and 14 days after with C. pneumoniae. in a of body in mice at day 5 after with the body of mice prior to but in body was in MyD88-/- mice at day 5 compared with the body of mice prior to infection with the of lung mice demonstrated an in lung compared with MyD88-/- mice at day 5 at day lung from mice to with a from acute inflammation and whereas MyD88-/- mice demonstrated an increased lung at day 14 with of lung inflammation These are by a increased number of inflammatory cells in the BAL of mice compared with MyD88-/- mice at day 5 Whereas inflammatory cells of mice were decreased by day 14 compared with day we not in inflammatory cells in the BAL the at day 14 we the of and in lung and BAL from infected MyD88-/- or mice at days and At day and in lung or BAL were in infected mice compared with MyD88-/- were unable to mount an early inflammatory response with the with lung and bacterial was a at day mice the inflammation and cytokines to whereas MyD88-/- mice developed a in IFN-γ and IL-1β levels and A and levels in lung and BAL of MyD88-/- mice at day with the of in the lung inflammation at this day and At day inflammatory cytokine levels in or lung were in whereas elevated in MyD88-/- mice These that MyD88 deficiency host innate bacterial clearance from the lungs, leading to a late and chronic lung of C. pneumoniae-infected MyD88-/- Mice to the from at 14 to the delayed but and chronic inflammation in the lungs of MyD88-/- mice on days 14 and was by delayed bacterial clearance and sustained bacterial we C. pneumoniae IFU in the lungs of MyD88-/- and mice at day 5 and day 14. were in the bacterial in infected lungs MyD88-/- mice and mice on day 5 at day 14 was a in bacterial burden in the lungs of whereas MyD88-/- mice to clear bacteria from their lungs The bacterial burden in the lungs of MyD88-/- mice on day 14 was comparable to the bacterial on day 5 after In we in C. pneumoniae-infected MyD88-/- mice of mice by day whereas of the infected mice the infection To was in MyD88-/- mice with C. pneumoniae, levels were determined in collected at 14 and MyD88-/- mice the of C. pneumoniae-specific as compared with mice both at day 14 and day (data not shown). MyD88-/- Mice of CD8+ and CD4+ T to with C. the of the of the inflammation in the lungs of MyD88-/- mice on day 5 day 14 we determined the of the inflammatory cells in the lung in and MyD88-/- mice C. pneumoniae infection. The number of levels on day 5 in the lungs of but their recruitment was delayed in the lungs of MyD88-/- and levels only on day 14. with the of the lung inflammation at day 5 the number of CD4+ T cells and CD8+ T cells increased at day 5 in the lungs of mice (but not MyD88-/- and at day 14 the number of lung CD4+ T cells and CD8+ T cells in increased in MyD88-/- mice MyD88-/- and in to C. pneumoniae the role of MyD88 in inflammatory host responses against C. pneumoniae infection in we from and MyD88-/- mice and infected with live C. pneumoniae at an of and and C. pneumoniae infection of and release in but not in MyD88-/- macrophages macrophages from wild-type and MyD88-deficient mice showed comparable ability in intracellular of C. pneumoniae in (data not shown). To the receptor in the of C. pneumoniae, we macrophages from TLR2-/-, and mice and infected with live C. pneumoniae at an of for TLR4-/- and macrophages to live C. pneumoniae by the macrophages were suggesting that at in TLR2 a role of MyD88 in C. pneumoniae-induced activation TLR2 or TLR4 with or in C. pneumoniae investigated or TLR4-/- mice have a in bacterial clearance and host defense against C. pneumoniae infection. TLR2-/-, or mice were inoculated intranasally with C. pneumoniae as described and at days 5 and 14 were and were In to MyD88-/- TLR2-/-, and TLR4-/- mice were to mount an acute inflammatory response early at day 5 and the lung inflammation by day similar to mice were in the inflammation in lungs of mice or TLR4-/- mice at days 5 or 14 Furthermore, in to MyD88-/- TLR2-/-, or TLR4-/- mice were to clear the bacteria from their lungs as well as the mice by day 14 was increased in the or TLR4-/- mice compared with mice the days after infection (data not shown). The major of studies are that MyD88-deficient mice to mount an effective lung defense against challenge with C. pneumoniae. data a role for MyD88-dependent signaling in innate immune defense against C. pneumoniae. We found that both and TLR4-/- mice were to mount a host MyD88-deficient mice were unable to up-regulate demonstrated delayed recruitment of CD8+ and CD4+ T cells to the did not were unable to clear the pathogen from their lungs, and exhibited compared with TLR2-/-, or TLR4-/- mice. MyD88-/- and macrophages showed comparable ability to the C. pneumoniae in vitro. This is with data that of Listeria was also found to be MyD88-independent B.T. Unanue E.R. J. Immunol. 2002; 169: 3869-3875Crossref PubMed Scopus (195) Google Scholar). a delayed MyD88-independent inflammatory response involving increased expression of IL-1β and IFN-γ did develop at day 14 after but in cases was to of C. pneumoniae-specific in MyD88-/- mice were not from in mice 14 and days after intranasal suggesting that MyD88-/- mice mount an though adaptive immune response against C. pneumoniae. a role for MyD88-dependent signaling in mounting a rapid and effective innate immune response against by C. pneumoniae in this These data are with the that the was an to proinflammatory cytokines and to cell to the site of infection that are to be in of C. pneumoniae, CD8+ T We also recruitment to the lungs of MyD88-deficient an well described by other studies B.T. Unanue E.R. J. Immunol. 2002; 169: 3869-3875Crossref PubMed Scopus (195) Google Scholar, S.J. Liggitt H.D. Hajjar A.M. Wilson C.B. J. Immunol. 2004; 172: 3377-3381Crossref PubMed Scopus (156) Google Scholar). TLR2 and TLR4 upon MyD88 to cytokine but we found that both TLR2- and TLR4-deficient mice were to mount an immune response that and the These the of the host the presence of C. pneumoniae. is that TLR2 and TLR4 redundant and it is that mice may have in host defenses against C. pneumoniae similar to we with mice. is that TLR2 TLR4 are in the of this in to TLRs, and also MyD88 for signaling, the that in MyD88-/- mice have been by signaling by receptors than by This is with a that also that signaling by TLR2 or TLR4 may not be for clearance of C. pneumoniae infection in mice after a challenge M. S. K. C. 2004; PubMed Scopus Google Scholar). data support in challenge model as MyD88-independent such as the or receptors other than TLRs such as the receptors may be important in some or may be in the response such that signaling may in the absence of MyD88. an involvement of signaling has been for C. pneumoniae-induced activation in B. A. B. S. S. N. S. J. 2004; PubMed Scopus Google Scholar). is also that and other receptors may a redundant for C. pneumoniae, but that the downstream adaptor MyD88 that is common to receptors is for an innate evidence is with the that MyD88 is for an effective host response to C. but the of the and the role of specific receptors the of on a body of of innate immune defenses a role for in pathogen of a rapid innate immune and of adaptive immune responses (6Akira S. Takeda K. Nat. Rev. Immunol. 2004; 4: 499-511Crossref PubMed Scopus (6623) Google Scholar, 7Beutler B. Nature. 2004; 430: 257-263Crossref PubMed Scopus (1247) Google Scholar) and it to involvement of TLRs in host defense against C. pneumoniae. We that TLRs can MyD88 to and we that are because of pathogen by one or more TLRs that MyD88. In support the model of pathogen and of host defenses, and the of MyD88 in host defense against C. pneumoniae. appears that the of MyD88-/- mice to immune cells to the lungs was a major contributor to the to clear pathogens from the lungs in MyD88-/- mice and reduced we found that MyD88-/- mice inflammatory cytokines CD8+ T cells to the lungs early in the of the infection at the 5 on at 14 both inflammation and recruitment of CD8+ T cells were in the lungs of MyD88-/- mice. the other were not early or late in MyD88-/- but were in lungs of wild-type mice. Therefore, not appear to be a contributor to the late chronic inflammation in MyD88-/- but be in rapid and clearance of pathogens from the lungs in the early of infection in mice. N. L. M. N. da Costa Durr S. Wagner H. Miethke T. J. Immunol. PubMed Scopus Google Scholar) that of C. pneumoniae in that of in the lungs of MyD88-/- mice to a reduced bacterial we found that MyD88-/- mice a in bacterial clearance from the lungs and the of bacteria at day 14 compared with day Thus, of did not in in bacterial in the lungs of MyD88-/- mice at days in Whereas N. L. M. N. da Costa Durr S. Wagner H. Miethke T. J. Immunol. PubMed Scopus Google Scholar) at early at days and after infection both early and late by days and after infection. We also found that MyD88-deficient mice have a in CD8+ T cell recruitment to the lung after infection. This MyD88-dependent signaling in recruitment of CD8+ T cells to of infection. CD8+ T cells are to be essential for of C. pneumoniae infection M.E. D. C. L. Wigzell H. J. Immunol. Google Scholar), of delayed CD8+ T cell recruitment to the lungs may an for the of that we in MyD88-deficient mice on days 5 and 14. Whereas studies have demonstrated in MyD88-deficient mice in the number of CD4+ and CD8+ T and in their ability to IFN-γ after activation M. G.M. Takeda K. Akira S. R. Nat. Immunol. 2001; 2: PubMed Scopus Google Scholar), more studies have shown that MyD88-deficient mice have in their CD8+ T cell response to acute infections such as S. L. A. M. Golenbock D.T. Eur. J. Immunol. PubMed Scopus Google Scholar, K. H. H. M. M. T. N. Y. A. N. T. Nature. PubMed Scopus Google Scholar). data are with the that the major MyD88-/- mice not clear the pathogen from their lungs and developed a chronic inflammation was that an early proinflammatory response was were not and recruitment of CD8+ T cells the infected lungs was that to the bacteria to in the lungs of MyD88-/- and that to clear the pathogen to the delayed but lung inflammation and increased We that MyD88 critically host defense to challenge with C. pneumonia in that an rapid innate immune response to clear the bacteria in this model be in the absence of MyD88, and that the of MyD88 deficiency is chronic lung inflammation and from an to C. pneumoniae infection. We M. for of the and We also for

References

22